Integragen

ALINT

Company Profile

  • Business description

    Integragen is engaged in the development of genetic biomarkers. It offers genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, as well as genomic research tools and solutions to microbiologic researchers.

  • Contact

    Genopole Campus 1 - Genavenir
    85 rue Henri Desbrueres
    Evry91000
    FRA

    T: +33 160910900

    https://www.integragen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    44

Stocks News & Analysis

stocks

AI stocks post big gains in Q3. These are the winners and losers

Alphabet and Teradyne post big gains, while Salesforce and Adobe were down in the quarter.
stocks

12 picks for an income portfolio - Q3 2025 update

Fifteen months in and passive income growth has exceeded my target.
stocks

ASX’s only dividend aristocrat reports

Cyclical headwinds persist but loan book and industrial property prop up earnings.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,280.0038.90-0.42%
CAC 407,971.78109.76-1.36%
DAX 4024,378.290.51-0.00%
Dow JONES (US)46,694.9763.31-0.14%
FTSE 1009,479.1412.11-0.13%
HKSE26,957.77183.15-0.67%
NASDAQ22,941.67161.160.71%
Nikkei 22547,944.762,175.264.75%
NZX 50 Index13,489.2424.85-0.18%
S&P 5006,740.2824.490.36%
S&P/ASX 2008,981.4034.80-0.39%
SSE Composite Index3,882.7820.250.52%

Market Movers